Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02814318 · ClinicalTrials.gov registry record
Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization
A clinical trial, sponsored by TriHealth.
- Terminated
- Registry status
- 41
- Enrollment target
NCT02814318: Clinical Trial study, sponsored by TriHealth.
NCT02814318 is a clinical trial that was terminated before completion, run by TriHealth. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02814318 was terminated before completion, sponsored by TriHealth.
- TERMINATED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The aim of this project is to identify the duration of vancomycin administration at which group B streptococcus (GBS) colonization is eradicated from the vaginal and recto-vaginal mucosa. This will aid in labor management and delivery planning to ensure that the mother receives adequate GBS prophylaxis while also minimizing the duration of exposure to vancomycin. In addition, this could prevent unnecessary prolonged hospitalization or septic workup of neonates whose mothers received vancomycin intrapartum. This study aims to identify the time after administration of IV vancomycin at which GBS colonies are 100% eradicated.
Interventions
- BIOLOGICAL Vaginal and rectovaginal swab cultures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2016-06 |
| Est. Completion | 2019-10 |
Why NCT02814318 stopped before completion
NCT02814318 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Vaginal and rectovaginal swab cultures is the first listed.
NCT02814318 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02814318 about?
NCT02814318 is a clinical study titled "Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization". The aim of this project is to identify the duration of vancomycin administration at which group B streptococcus (GBS) colonization is eradicated from the vaginal and recto-vaginal mucosa. This will aid in labor management and delivery planning to ensure that the mother receives adequate GBS prophyla...
What is the current status of trial NCT02814318?
This trial is currently terminated. The enrollment target is 41 participants. The study started on 2016-06. Estimated completion is 2019-10.
What interventions are being tested in trial NCT02814318?
The interventions under investigation include: Vaginal and rectovaginal swab cultures (BIOLOGICAL).
Who is sponsoring clinical trial NCT02814318?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia